1
|
Shu X, Liu W, Liu H, Qi H, Wu C, Ran YL. Analysis of microRNA expression in CD133 positive cancer stem‑like cells of human osteosarcoma cell line MG-63. PeerJ 2021; 9:e12115. [PMID: 34557357 PMCID: PMC8420872 DOI: 10.7717/peerj.12115] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2021] [Accepted: 08/15/2021] [Indexed: 12/13/2022] Open
Abstract
Osteosarcoma (OS) is a primary malignant tumor of bone occurring in young adults. OS stem cells (OSCs) play an important role in the occurrence, growth, metastasis, drug resistance and recurrence of OS. CD133 is an integral membrane glycoprotein, which has been identified as an OSC marker. However, the mechanisms of metastasis, chemoresistance, and progression in CD133(+) OSCs need to be further explored. In this study, we aim to explore differences in miRNA levels between CD133(+) and CD133(-) cells from the MG-63 cell line. We found 20 differentially expressed miRNAs (DEmiRNAs) (16 upregulated and 4 downregulated) in CD133(+) cells compared with CD133(-) cells. Hsa-miR-4485-3p, hsa-miR-4284 and hsa-miR-3656 were the top three upregulated DEmiRNAs, while hsa-miR-487b-3p, hsa-miR-493-5p and hsa-miR-431-5p were the top three downregulated DEmiRNAs. In addition, RT-PCR analysis confirmed that the expression levels of hsa-miR-4284, hsa-miR-4485-3p and hsa-miR-3656 were significantly increased, while the expression levels of hsa-miR-487b-3p, hsa-miR-493-5p, and hsa-miR-431-5p were significantly decreased in CD133(+) cells compared with CD133(-) cells. Moreover, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis revealed that predicted or validated target genes for all 20 DEmiRNAs or the selected 6 DEmiRNAs participated in the "PI3K-Akt signaling pathway," "Wnt signaling pathway," "Rap1 signaling pathway," "Cell cycle" and "MAPK signaling pathway". Among the selected six DEmiRNAs, miR-4284 was especially interesting. MiR-4284 knockdown significantly reduced the sphere forming capacity of CD133(+) OS cells. The number of invasive CD133(+) OS cells was markedly decreased after miR-4284 knockdown. In addition, miR-4284 knockdown increased the p-β-catenin levels in CD133(+) OS cells. In conclusion, RNA-seq analysis revealed DEmiRNAs between CD133(+) and CD133(-) cells. MiRNAs might play significant roles in the function of OSCs and could serve as targets for OS treatment. MiR-4284 prompted the self-renewal and invasion of OSCs. The function of miR-4284 might be associated with the Wnt signaling pathway.
Collapse
Affiliation(s)
- Xiong Shu
- Beijing Research Institute of Traumatology and Orthopaedics, Beijing JiShuiTan Hospital, Beijing, China
| | - Weifeng Liu
- Department of Orthopaedic Oncology Surgery, Beijing Jishuitan Hospital, Peking University, Beijing, China
| | - Huiqi Liu
- Medical College of Qinghai University, Xining, China
| | - Hui Qi
- Beijing Research Institute of Traumatology and Orthopaedics, Beijing JiShuiTan Hospital, Beijing, China
| | - Chengai Wu
- Beijing Research Institute of Traumatology and Orthopaedics, Beijing JiShuiTan Hospital, Beijing, China
| | - Yu-Liang Ran
- State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| |
Collapse
|
2
|
Zhu SJ, Wang X, Hu SL, Fang Y, Guan BX, Li J, Li G, Xu JY. Clinical Significance and Biological Function of miR-1274a in Non-small Cell Lung Cancer. Mol Biotechnol 2021; 64:9-16. [PMID: 34427871 DOI: 10.1007/s12033-021-00385-w] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2021] [Accepted: 08/16/2021] [Indexed: 12/23/2022]
Abstract
Since the discovery of microRNAs (miRNAs) as a class of important regulatory molecules, miRNAs are involved in the occurrence and development of tumors. In this paper, we aimed to identify the role of miR-1274a in non-small cell lung cancer (NSCLC). The miR-1274a expression levels in four NSCLC cells and tissues from 125 patients were determined by qRT-PCR assays. Kaplan-Meier survival curves and Cox regression analysis were used to examine the prognostic significance of miR-1274a in NSCLC patients. The CCK-8 and Transwell assays were performed to evaluate the cell proliferation, invasion, and migration ability of NSCLC cells. The miR-1274a expression levels were significantly higher in NSCLC tissues than in adjacent normal tissues, and overexpression of miR-1274a had a poor prognosis in NSCLC patients. Functional studies in two NSCLC cell lines have shown that overexpression of miR-1274a could promote cell proliferation, migration, and invasion. miR-1274a expression levels are upregulated in NSCLC tissues, and a high expression is associated with a poor prognosis in patients with NSCLC. Moreover, miR-1274a promotes cell proliferation, migration, and invasion. Based on our findings, miR-1274a may act as a tumor miRNA in the occurrence and development of NSCLC.
Collapse
Affiliation(s)
- Shi-Jia Zhu
- Clinical Oncology Center, Hong Kong University Shenzhen Hospital, Shenzhen, 518000, Guangdong, China
| | - Xiao Wang
- Department of Radiation Oncology, The Affiliated Tumor Hospital of Harbin Medical University, No. 150 Haping Road, Nangang District, Harbin, 150040, Heilongjiang, China
| | - Song-Liu Hu
- Department of Radiation Oncology, The Affiliated Tumor Hospital of Harbin Medical University, No. 150 Haping Road, Nangang District, Harbin, 150040, Heilongjiang, China
| | - Yu Fang
- Department of Phase I Clinical Trial, The Affiliated Tumor Hospital of Harbin Medical University, Harbin, 150040, Heilongjiang, China
| | - Bi-Xi Guan
- Department of Radiation Oncology, The Affiliated Tumor Hospital of Harbin Medical University, No. 150 Haping Road, Nangang District, Harbin, 150040, Heilongjiang, China
| | - Jian Li
- Department of Radiation Oncology, The Affiliated Tumor Hospital of Harbin Medical University, No. 150 Haping Road, Nangang District, Harbin, 150040, Heilongjiang, China
| | - Gen Li
- Department of Radiation Oncology, The Affiliated Tumor Hospital of Harbin Medical University, No. 150 Haping Road, Nangang District, Harbin, 150040, Heilongjiang, China
| | - Jian-Yu Xu
- Department of Radiation Oncology, The Affiliated Tumor Hospital of Harbin Medical University, No. 150 Haping Road, Nangang District, Harbin, 150040, Heilongjiang, China.
| |
Collapse
|